PNC-27 (Anti-Cancer Peptide)

PNC-27 is a peptide that was developed for research purposes and has been studied for its potential anti-cancer properties. It belongs to a class of peptides that interact with cell membranes and is known to be a membrane-active peptide. The mechanism of action of PNC-27 involves targeting cancer cells and inducing cell death (apoptosis) by disrupting their membranes.

The peptide has shown the ability to bind to the HDM-2 protein on the surface of cancer cells, which is a mechanism that prevents the cancer cells from blocking the apoptosis pathway. PNC-27 has been researched in preclinical studies, primarily in vitro (test tube experiments) and in vivo (animal studies), for its potential to treat various forms of cancer, including melanoma, breast cancer, and pancreatic cancer.

Amount in vial: 5mg

All DeusMedical vials come lyophilized with mannitol